Indiana online map now includes COVID-19 vaccine sites with new reminder

The bivalent COVID-19 booster, approved by the CDC on Sept. 1, helps protect Hoosiers against the omicron and delta strains of the virus.  - FILE PHOTO: Justin Hicks/IPB News

The bivalent COVID-19 booster, approved by the CDC on Sept. 1, helps protect Hoosiers against the omicron and delta strains of the virus.

FILE PHOTO: Justin Hicks/IPB News


Updated September 13 at 5:20 p.m.

Hoosiers can now find COVID-19 vaccine sites with the new reminder on the state’s online map, available at OurShot.IN.gov.

The so-called bivalent booster, approved by the Centers for Disease Control and Prevention earlier this month, helps protect Hoosiers against the omicron and delta strains of the virus. Previous recalls only covered the original strain of COVID-19.

In a statement, the state’s health commissioner, Dr. Kris Box, said having a vaccine that specifically targets the current dominant strain of the virus is especially important as we approach fall and winter, when illnesses like COVID-19 are more prevalent.

READ MORE: Indiana surpasses 1.9 million confirmed COVID-19 cases as reported infections plateau




Join the conversation and sign up for the Indiana Two-Way. Text “Indiana” to 73224. Your comments and questions in response to our weekly text message help us find the answers you need about COVID-19 and other statewide issues.


Hoosiers cannot yet schedule appointments for the new recall on the state’s website. The Indiana Department of Health encourages them to contact a pharmacy or health care provider directly or call 211 for help. Online scheduling should be available later this month.


CLARIFICATION: A previous version of this story stated that Hoosiers could not yet schedule appointments for the new online booster. For clarity, it has been changed to Hoosiers cannot yet schedule appointments for the new recall on the state’s website.


Contact reporter Brandon at bsmith@ipbs.org or follow him on Twitter at @brandonjsmith5.

Reduce :ipr: 1


Comments are closed.